Aberdeen Group
NEO icon

Aberdeen Group’s NeoGenomics NEO Stock Holding History

Aberdeen Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
2,026,893
+227,954
+13% +$2.4M 0.02% 496
2025
Q4 		$21.2M Buy
1,798,939
+1,006,676
+127% +$10.9M 0.03% 409
2025
Q3 		$6.12M Buy
792,263
+379,165
+92% +$2.66M 0.01% 679
2025
Q2 		$3.02M Hold
413,098
– – 0.01% 750
2025
Q1 		$3.92M Buy
+413,098
New +$5.16M 0.01% 704

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aberdeen Group's NEO Position: Q1 2026 in Review

Aberdeen Group increased its NeoGenomics (NEO) stake by 13% in Q1 2026, buying an estimated $2.4M and bringing the position to 2,026,893 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #496.

Aberdeen Group first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. The position peaked at $21.2M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Aberdeen Group held 2,026,893 shares of NeoGenomics worth $15M as of Q1 2026.
  • Aberdeen Group bought 227,954 NeoGenomics shares in Q1 2026, an estimated $2.4M.
  • NeoGenomics made up 0.02% of Aberdeen Group's portfolio in Q1 2026, its #496 holding.
  • Aberdeen Group first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • Aberdeen Group's NeoGenomics position peaked at $21.2M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.